The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Long-term Results of the Stapled Transanal Rectal Resection (STARR) Operation Proposed in the Treatment of a Rectocele (STARRLOC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT05037422
Recruitment Status : Recruiting
First Posted : September 8, 2021
Last Update Posted : January 3, 2024
Sponsor:
Information provided by (Responsible Party):
University Hospital, Grenoble

Tracking Information
First Submitted Date April 29, 2021
First Posted Date September 8, 2021
Last Update Posted Date January 3, 2024
Actual Study Start Date October 16, 2021
Estimated Primary Completion Date October 24, 2024   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures
 (submitted: August 31, 2021)
Long term results of the STARR operation. [ Time Frame: 10 years ]
Dyschezia postoperatively
Original Primary Outcome Measures Same as current
Change History
Current Secondary Outcome Measures Not Provided
Original Secondary Outcome Measures Not Provided
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title Long-term Results of the Stapled Transanal Rectal Resection (STARR) Operation Proposed in the Treatment of a Rectocele
Official Title Single-center Retrospective Study of the Long-term Results of the Stapled TransAnal Rectal Resection (STARR) Operation Proposed in the Treatment of a Rectocele in Consecutive Patients
Brief Summary Rectal static disorders, including the rectocele, represent a frequent functional pathology which affects the quality of life of affected patients. Among vaginal treatments, the STARR technique corresponds to rectal resection by transanal approach using a stapler. The American Gastroenterology Association (AGA) has concluded that service to patients is insufficient. The technical and functional results published are mostly short-term studies. The investigators seek to assess the technical and functional results of Operation STARR, based on a series of consecutive expert center cases, to confirm or refute the conclusions of the AGA recommendations.
Detailed Description Not Provided
Study Type Observational
Study Design Observational Model: Other
Time Perspective: Other
Target Follow-Up Duration Not Provided
Biospecimen Not Provided
Sampling Method Non-Probability Sample
Study Population All adult patients operated on for rectocele in the digestive surgery and emergency department of the CHU de Grenoble will be included, provided they are not opposed.
Condition Rectocele; Female
Intervention Procedure: STARR surgery
This intervention is carried out under general anesthesia or spinal anesthesia. It consists of the circular resection of the "surplus" of rectal mucosa. Rectal resection and suturing is performed using automatic mechanical forceps introduced through the anus.
Study Groups/Cohorts Not Provided
Publications *

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status Recruiting
Estimated Enrollment
 (submitted: August 31, 2021)
77
Original Estimated Enrollment Same as current
Estimated Study Completion Date November 24, 2024
Estimated Primary Completion Date October 24, 2024   (Final data collection date for primary outcome measure)
Eligibility Criteria

Inclusion Criteria:

  • Patient operated for rectocele for 10 or more
  • Age 18 and over
  • Informed patients

Exclusion Criteria:

  • Patient objection
Sex/Gender
Sexes Eligible for Study: Female
Ages 18 Years and older   (Adult, Older Adult)
Accepts Healthy Volunteers Not Provided
Contacts
Contact: Sandrine BARBOIS, MD 0033476765526 sandrinebarbois@yahoo.fr
Listed Location Countries France
Removed Location Countries  
 
Administrative Information
NCT Number NCT05037422
Other Study ID Numbers 38RC21.144
Has Data Monitoring Committee No
U.S. FDA-regulated Product
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
IPD Sharing Statement Not Provided
Current Responsible Party University Hospital, Grenoble
Original Responsible Party Same as current
Current Study Sponsor University Hospital, Grenoble
Original Study Sponsor Same as current
Collaborators Not Provided
Investigators
Principal Investigator: Jean-Luc Faucheron, MD CHU Grenoble Alpes
PRS Account University Hospital, Grenoble
Verification Date January 2024